SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001662524-18-000009
Filing Date
2018-05-07
Accepted
2018-05-04 21:37:34
Documents
53
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 AKCEA THERAPEUTICS, INC. 10-Q 3-31-2018 form10q.htm 10-Q 919679
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 38034
3 EXHIBIT 10.5 ex10_5.htm EX-10.5 165518
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 13462
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 13492
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 6921
  Complete submission text file 0001662524-18-000009.txt   4577957

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT akca-20180331.xml EX-101.INS 719145
8 XBRL TAXONOMY EXTENSION SCHEMA akca-20180331.xsd EX-101.SCH 46239
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20180331_cal.xml EX-101.CAL 48907
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20180331_def.xml EX-101.DEF 198885
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20180331_lab.xml EX-101.LAB 601067
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20180331_pre.xml EX-101.PRE 295471
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38137 | Film No.: 18809528
SIC: 2834 Pharmaceutical Preparations